Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...

Researchers have found in a new study that semaglutide could provide cardiovascular benefits to high-risk patients even ...

Within six months, the drug reduced the risk of cardiovascular death by 50% and cut the risk of needing urgent treatment due ...

Weight-loss drug Wegovy can protect the heart even before significant weight loss, researchers found (James Manning/PA) The weight-loss drug Wegovy slashes the risk of heart disease even before ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed pounds, data suggests. The drug, which contains the active ingredient semaglutide, works by reducing food ...